Reckitt Benckiser Stock - Thursday chart picture and technical levels
18.06.2026 - 22:07:53 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 20:06 UTC. Details in the imprint.
Reckitt Benckiser (GB00B24CGK77) remains a staple of the UK consumer staples sector, with its stock trading steadily in London on Thursday. With no fresh market-moving corporate headlines confirmed today, the focus shifts to the chart picture and recent technical levels, based on current exchange data.
Background and price data on Reckitt Benckiser stock
All news, documents and price information on Reckitt Benckiser stock can be found bundled on the issuer’s profile and in the investor relations area.
What Thursday’s chart shows
On the London Stock Exchange, Reckitt Benckiser shares recently changed hands at around 4,575 pence, after opening close to 4,554 pence and compared with a previous close of 4,601 pence. That points to a modestly softer session rather than a sharp move.
MarketBeat data put the group’s market capitalization at roughly GBP 29.5 billion, with a price/earnings ratio of about 13 based on current estimates. Trading volume on Thursday morning was a little above 1 million shares, which is consistent with typical liquidity for the stock.
Key technical levels and volatility
Chart services show Reckitt Benckiser trading not far from mid-range levels seen over recent months, rather than at fresh highs or lows, which suggests a comparatively muted volatility backdrop for now. Short-term traders are watching support near recent closing prices and resistance around the 4,700 pence area.
Against this backdrop, the shares continue to reflect a defensive consumer profile rather than a high-beta growth story, with the valuation and yield more in focus than aggressive price swings. For chart-oriented investors, the next impulses will likely come from news or rating changes rather than pure technicals.
How analysts frame the stock
Consensus data compiled by MarketBeat show a mix of Buy, Hold and Sell recommendations on Reckitt Benckiser, resulting in an overall Hold stance on the shares. The average analyst price target sits moderately above the current quote, underlining a cautious but not negative view.
Recent analyst commentary has focused on execution after past operational issues, the resilience of branded household and health products, and the company’s ability to protect margins in a competitive environment. Net-net, the stock is seen as a stable income name rather than a momentum trade.
The dividend and income profile
According to data from Hargreaves Lansdown, Reckitt Benckiser paid a dividend of GBP 1.278 per share, with the most recent payment date on 06/12/2026 and an ex-dividend date of 04/09/2026. This corresponds to a dividend yield of around 4.6% at current prices.
For income-focused holders, this yield is a key component of the investment case, especially when combined with the company’s long record of paying dividends through different economic cycles. The payout is funded by cash flows from a broad portfolio of everyday consumer brands.
What the company sells
Reckitt Benckiser generates its revenue from branded consumer health, hygiene and nutrition products, including well-known names such as Dettol disinfectants, Finish dishwasher tablets, Durex condoms and Nurofen pain relief. The business model is built on scale, brand strength and global distribution.
Where the stock trades today
The shares of Reckitt Benckiser (GB00B24CGK77) trade on the London Stock Exchange at 4,575.00 pence as of 06/18/2026, 16:30 BST.
Reckitt Benckiser at a glance
- Company: Reckitt Benckiser Group plc
- ISIN: GB00B24CGK77
- WKN: A0M1W6
- Ticker: RKT
- Venue: London Stock Exchange
- Price (as of 06/18/2026, 16:30 BST): 4,575.00 pence
- Market cap: 29.5 billion GBP (as of 06/18/2026)
- Sector / Industry: Consumer Staples / Household & Personal Products
- Index membership: FTSE 100
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
